Joincare Pharmaceutical Group Industry Company Overview
- Year Founded
-
1992
- Status
-
Public
- Employees
-
13,575
- Stock Symbol
-
600380
- Investments
-
6
- Share Price
-
$1.55
- (As of Thursday Closing)
Joincare Pharmaceutical Group Industry Company General Information
Description
Joincare Pharmaceutical Group Industry Co Ltd is an integrated pharmaceutical company, the business scope covers healthcare products, APIs, final dosage forms, prescription drugs, OTCs, Chinese traditional medicine, chemical drugs, and testing agents. APIs are antibiotic series and their intermediates 7ACA, 4AA and F9. Prescription drugs focus on the realms of the digestive tract, a blood vessel of heart and brain, infection, tumor, nervous cerebrovascular section, urinary system etc. OTCs include gastrointestinal drug Dele-Livzon, Live Bifidobacterium Preparation, oral ulcer drugs Yiketie, cold medicine Antiviral Oral Granule, External use skin medicine.
Contact Information
Website
www.joincare.comCorporate Office
- Joincare Pharmaceutical Group Building, No. 17 Langshan Road
- North District, High-tech Zone, Nanshan District
- Shenzhen, Guangdong 518057
- China
Corporate Office
- Joincare Pharmaceutical Group Building, No. 17 Langshan Road
- North District, High-tech Zone, Nanshan District
- Shenzhen, Guangdong 518057
- China
Joincare Pharmaceutical Group Industry Company Stock Performance
As of 12-Nov-2026, Joincare Pharmaceutical Group Industry Company’s stock price is $1.55. Its current market cap is $2.83B with 1.83B shares.
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $1.55 | $1.54 | $1.34 - $1.81 | $2.83B | 1.83B | 18.3M | $0.09 |
Joincare Pharmaceutical Group Industry Company Financials Summary
As of 30-Sep-2026, Joincare Pharmaceutical Group Industry Company has a trailing 12-month revenue of $1.95B.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 2,880,371 | 2,832,434 | 2,859,224 | 3,269,998 |
| Revenue | 1,945,349 | 2,115,848 | 2,176,791 | 2,352,881 |
| EBITDA | 357,732 | 528,671 | 570,580 | 584,338 |
| Net Income | 164,065 | 185,717 | 193,238 | 203,930 |
| Total Assets | 5,170,319 | 5,061,572 | 4,892,827 | 5,129,098 |
| Total Debt | 705,765 | 601,341 | 725,413 | 836,896 |
Joincare Pharmaceutical Group Industry Company Patents
Joincare Pharmaceutical Group Industry Company Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026208813-A1 | Solid dispersion, pharmaceutical composition containing same, and preparation method therefor and use thereof | Pending | 31-Mar-2025 | ||
| WO-2026145491-A1 | Quantitative detection method for crystal of cap-dependent endonuclease inhibitor and crystal form of cap-dependent endonuclease inhibitor | Pending | 31-Dec-2024 | ||
| WO-2023051499-A1 | Drug assembly containing formoterol fumarate inhalation solution and use thereof | Inactive | 28-Sep-2021 | ||
| EP-4393485-A1 | Pharmaceutical assembly comprising tobramycin inhalation solution and use thereof | Inactive | 18-Sep-2021 | ||
| EP-4393485-A4 | Pharmaceutical assembly comprising tobramycin inhalation solution and use thereof | Inactive | 18-Sep-2021 | A61K31/7036 |
Joincare Pharmaceutical Group Industry Company Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Joincare Pharmaceutical Group Industry Company Investments (6)
Joincare Pharmaceutical Group Industry Company’s most recent deal was a Later Stage VC with Jinrui Foundation. The deal was made on 28-Jul-2023.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Jinrui Foundation | 28-Jul-2023 | Later Stage VC | Drug Discovery | ||
| Sheo Pharmaceutical | 06-Jun-2023 | Later Stage VC | Drug Discovery | ||
| BaiNing YingChuang | 01-Oct-2020 | Corporate | Monitoring Equipment | ||
| Novastage | 13-Jul-2020 | Corporate | Drug Discovery | ||
| Feellife | 02-Jul-2019 | Later Stage VC | Medical Supplies |
Joincare Pharmaceutical Group Industry Company ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
27.7 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,585
Rank
Percentile
Pharmaceuticals
Industry
of 852
Rank
Percentile
Pharmaceuticals
Subindustry
of 354
Rank
Percentile
Joincare Pharmaceutical Group Industry Company Exits (1)
Joincare Pharmaceutical Group Industry Company’s most recent exit was on 13-Jul-2020 from Novastage. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Novastage | 13-Jul-2020 | Completed |
|
Joincare Pharmaceutical Group Industry Company FAQs
-
When was Joincare Pharmaceutical Group Industry Company founded?
Joincare Pharmaceutical Group Industry Company was founded in 1992.
-
Where is Joincare Pharmaceutical Group Industry Company headquartered?
Joincare Pharmaceutical Group Industry Company is headquartered in Shenzhen, China.
-
What is the size of Joincare Pharmaceutical Group Industry Company?
Joincare Pharmaceutical Group Industry Company has 13,575 total employees.
-
What industry is Joincare Pharmaceutical Group Industry Company in?
Joincare Pharmaceutical Group Industry Company’s primary industry is Pharmaceuticals.
-
Is Joincare Pharmaceutical Group Industry Company a private or public company?
Joincare Pharmaceutical Group Industry Company is a Public company.
-
What is Joincare Pharmaceutical Group Industry Company’s stock symbol?
The ticker symbol for Joincare Pharmaceutical Group Industry Company is 600380.
-
What is the current stock price of Joincare Pharmaceutical Group Industry Company?
As of 12-Nov-2026 the stock price of Joincare Pharmaceutical Group Industry Company is $1.55.
-
What is the current market cap of Joincare Pharmaceutical Group Industry Company?
The current market capitalization of Joincare Pharmaceutical Group Industry Company is $2.83B.
-
What is Joincare Pharmaceutical Group Industry Company’s current revenue?
The trailing twelve month revenue for Joincare Pharmaceutical Group Industry Company is $1.95B.
-
What is Joincare Pharmaceutical Group Industry Company’s annual earnings per share (EPS)?
Joincare Pharmaceutical Group Industry Company’s EPS for 12 months was $0.09.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
